Trio Clinical Research Relocates Headquarters to Accommodate Growth
July 8, 2009, Raleigh, NC –
Trio Clinical Research, a leading clinical research services company supporting the pharmaceutical, biotechnology and medical device industry announced today a relocation of the company’s headquarters. The relocation provides Trio with larger office space to accommodate the company’s growth, and more amenable facilities for staff and visiting customers.
Trio’s new headquarters office, with 14,000 square feet of space, is located at 8045 Arco Corporate Drive, Suite 200, Raleigh, North Carolina 27617. The new office is conveniently located in Brier Creek Corporate Center and is within five miles of Raleigh-Durham International airport.
“We are thrilled with the relocation of our headquarters office to a larger and more modern facility. This move is just one of several important initiatives positioning Trio as a comprehensive provider of clinical research services. Our new facility offers us an additional 3,000 square feet, affording not only additional office space for new employees, but also more upscale conference space for hosting client meetings,” said Betsy Brown, Chief Operating Officer of Trio Clinical Research.
Trio will be hosting an Open House reception for customers, contractors and local business leaders. Details of the event will be announced in the coming days.
About Trio Clinical Research
Trio Clinical Research is an innovative clinical research services company supporting the pharmaceutical, biotechnology and medical device industries in their quest to bring novel products to the market. Founded in 2003, Trio provides comprehensive clinical, functional outsourcing and resourcing services across a wide-range of therapeutic areas in phase I-IV clinical research. Trio’s extensive customer base includes a majority of the world’s top pharmaceutical and biotech companies.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
